FCP OP MEDICAL BioHelth-Trends

FCP OP MEDICAL BioHelth-Trends - Investments & Acquisitions

Show Real Data FCP OP MEDICAL BioHelth-Trends Investments
See all Recent Investments
Date Company Round Amount Co-investors
2010-05-19NOXXON PharmaSeries D$42MAndera Partners, Berlin Capital Fund, Commerzbank - Equity Markets and Commodities Unit, DEWB, Dieckell Vermogensverwaltung, Dow Venture Capital, Excalibur Group, GBK Beteiligungen, Hannover Finanz, HF Fonds VII Unternehmensbeteiligungs, IBB Beteiligungsgesellschaft, IBG Beteiligungsgesellschaft, KfW Mittelstandsbank, Medical Strategy, Oppenheim Pramerica Asset Management, Peppermint VenturePartners, Pfizer Venture Investments, Provinzial Beteiligungsgesellschaft, Seventure Partners, Sofinnova Partners, TVM Capital Life Science, VC Venture-Beteiligungen, and WeHaCo Unternehmensbeteiligungs
2007-05-03NOXXON PharmaSeries C$50MAndera Partners, DEWB, Dieckell Vermogensverwaltung, Dow Venture Capital, IBG Beteiligungsgesellschaft, Seventure Partners, Sofinnova Partners, TVM Capital Life Science, and VC Fonds Kreativwirtschaft Berlin
2007-02-09Ziopharm OncologyPIPE - II$30.88MAWM Investment Company, Diamondback Capital Management, Essex Woodlands, Henderson Global Investors, J.P. Morgan Chase & Co., LBI Group, Medical Strategy, Millennium Management, Oppenheim Pramerica Asset Management, Panacea Asset Management, PHARMA/wHEALTH, ProQuest Investments, and PTV Sciences
2006-05-05Ziopharm OncologyPIPE$37MAbu Dhabi Investment Authority, Andrew Carter Capital, Broadlawn Capital Management, Bushido Capital Partners, Clarion Capital Partners, Cycad Group, Dorset Management Corporation, Downsview Capital, Emerging Technology Center, H & A Lux VCH Expert Biotech, Hackney Group, Hauck & Aufhauser, Henderson Global Investors, Highbridge Capital Management, Hollis Capital Management, Iroquois Capital Group, Knott Partners, LBI Group, Lewis Asset Management, Medical Strategy, Mehta Partners, Millennium Management, Mosaix Ventures, Panacea Asset Management, ProQuest Investments, Quantitative Bioequities Management, Riverside Contracting, Sterling Securities International, and Visium Asset Management
See all 4 investments